SavedAdd your journal

Journals / Hitit Medical Journal / 2022 / Cilt: 4 - Sayı: 1

2 Years in the Shadow of the Pandemic: COVID-19 with Questions

Pandeminin Gölgesinde Geçen 2 Yıl: Sorularla COVID-19

İmdat KILBAŞ
Elmas Pınar KAHRAMAN KILBAŞ
İhsan CİFTCİ
Pages
22–28
Publication Date
2022-02-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, some questions about the virology, immunology, diagnosis, comorbidities, epidemiology, treatment and vaccine development studies of COVID-19 are answered.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The COVID-19 outbreak first started in China in 2019.
📊
Key Findings & Data:This disease, caused by the SARS-CoV-2 virus, soon became a pandemic.
💡
Conclusion & Impact:In this article, some questions about the virology, immunology, diagnosis, comorbidities, epidemiology, treatment and vaccine development studies of COVID-19 are answered.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:SARS-CoV-2 · Aşı · COVID-19

Abstract

The COVID-19 outbreak first started in China in 2019. This disease, caused by the SARS-CoV-2 virus, soon became a pandemic. The social problems brought about by COVID-19 have raised many questions about basic and evidence-based information about this disease. Vaccine and treatment studies related to COVID-19 continue at an increasing rate. In this article, some questions about the virology, immunology, diagnosis, comorbidities, epidemiology, treatment and vaccine development studies of COVID-19 are answered.

Özet

COVID-19 salgını ilk olarak 2019 yılında Çin’de başlamıştır. SARS-CoV-2 virüsünün neden olduğu bu hastalık kısa süre içinde bir pandemi haline gelmiştir. COVID-19’un beraberinde getirdiği toplumsal problemler, bu hastalıkla ilgili temel ve kanıta dayalı bilgilere yönelik çok sayıda soru gündeme getirmiştir. COVID-19 ile ilgili aşı ve tedavi çalışmaları artan hızda devam etmektedir. Bu makalede, COVID-19’un virolojisi, immünolojisi, tanısı, komorbiditeleri, epidemiyolojisi, tedavisi ve aşı geliştirme çalışmaları hakkında bazı sorular cevaplanmıştır.

🔖

Cite This Article

KILBAŞ, İ., KILBAŞ, E. P. K., CİFTCİ, İ. (2022). 2 Years in the Shadow of the Pandemic: COVID-19 with Questions. Hitit Medical Journal, Cilt: 4 - Sayı: 1, 22–28. https://ajindex.com/articles/421127

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA 2020;323:709-710. 2. https://www.who.int/publications/m/item/draft-landscapeof-covid-19-candidate-vaccines (Erişim tarihi 27 Kasım 2021)
  2. De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016;14:523–534
  3. Zhou P, Yang XL, Wang XG et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-273
  4. Li W, Moore MJ, Vasilieva N et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450-454
  5. Tsan-Yuk LT, Ho-Hin SM, Tong YG et al. Identifying SARS-CoV-2- related coronaviruses in Malayan pangolins. Nature 2020; 583:282-285
  6. Weston S, Frieman MB. COVID-19: knowns, unknowns, and questions. mSphere 2020;5:1-5
  7. Hui KPY, Cheung MC, Perera RAPM et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med 2020;8:687-695
  8. Wölfel R, Corman VM, Guggemos W et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020;581:465-469
  9. Arabacı C, Aydın Tutak G, Eroglu Kesim B et al. SARS CoV-2 Virüsünün Özellikleri ve Mikrobiyolojik Tanısı. Eur Arc Med Res 2020;36:10-20
  10. Cevik M, Bamford CG, Ho A. COVID-19 pandemic-a focused review for clinicians. Clin Microbiol Infect 2020;26:842-847
  11. Klompas M, Baker MA, Rhee C. Airborne transmission of SARS-CoV-2: theoretical considerations and available evidence. JAMA 2020;324:441-442
  12. Bialek S, Gierke R, Bowen V. Coronavirus Disease 2019 in Children-United States. MMWR Morb Mortal Wkly Rep 2020;69:422–426
  13. Parri N, Lenge M, Buonsenso D. Children with COVID-19 in pediatric emergency departments in Italy. N Engl J Med 2020;383:187-190. 15. https://www.healthline.com/health-news/risks-of-the-deltavariant-for-vaccinated-vs-unvaccinated-people (Erişim tarihi 3 Ekim 2021)
  14. Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and complications of COVID-19. Future Microbiol 2020;15:1287-1305
  15. Soraya GV, Ulhaq ZS. Crucial Laboratory Parameters in COVID19 Diagnosis and Prognosis:An Updated Meta-Analysis. SSRN Electronic Journal 2020;155:143–151
  16. Moutchia J, Pokharel P, Kerri A et al. Clinical laborato